115 related articles for article (PubMed ID: 2148815)
1. Effect of peripheral injection of arginine vasopressin and its receptor antagonist on burn shock in the rat.
Sun K; Gong A; Wang CH; Lin BC; Zhu HN
Neuropeptides; 1990 Sep; 17(1):17-22. PubMed ID: 2148815
[TBL] [Abstract][Full Text] [Related]
2. Comparison of selective arginine vasopressin V1 and V2 receptor antagonists on burn shock in the rat.
Sun K; Lin BC; Wang CH; Zhu HN
Cardiovasc Res; 1991 Apr; 25(4):265-9. PubMed ID: 1884385
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of beta-endorphin in the deteriorating effect of arginine vasopressin on burn shock in rats.
Sun K; Lin BC; Zhang C; Wang CH; Zhu HN
Circ Shock; 1989 Nov; 29(3):167-74. PubMed ID: 2591029
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
Kopia GA; Valocik RE
J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
[TBL] [Abstract][Full Text] [Related]
6. Spinal vasopressin modulates the reflex cardiovascular response to static contraction.
Stebbins CL; Ortiz-Acevedo A; Hill JM
J Appl Physiol (1985); 1992 Feb; 72(2):731-8. PubMed ID: 1532795
[TBL] [Abstract][Full Text] [Related]
7. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
Hinojosa C; Haywood JR
J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
[TBL] [Abstract][Full Text] [Related]
8. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
Thornhill J; Gregor L; Pittman Q
Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
[TBL] [Abstract][Full Text] [Related]
9. Reflex cardiovascular response to exercise is modulated by circulating vasopressin.
Stebbins CL
Am J Physiol; 1992 Nov; 263(5 Pt 2):R1104-9. PubMed ID: 1359798
[TBL] [Abstract][Full Text] [Related]
10. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
[TBL] [Abstract][Full Text] [Related]
11. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
[TBL] [Abstract][Full Text] [Related]
12. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
Johnson JV; Bennett GW; Hatton R
J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
[TBL] [Abstract][Full Text] [Related]
13. V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs.
Liard JF
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1325-9. PubMed ID: 2974249
[TBL] [Abstract][Full Text] [Related]
14. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
Clineschmidt BV; Lis EV
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
[TBL] [Abstract][Full Text] [Related]
16. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
László FA; Laczi F; Janáky T; Baláspiri L
Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
[TBL] [Abstract][Full Text] [Related]
17. Contribution of vasopressin in dexamethasone-induced hypertension in rats.
Iijima F; Malik KU
Hypertension; 1988 Feb; 11(2 Pt 2):I42-6. PubMed ID: 3346065
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with vasodilator or V1-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats.
Chiu EK; McNeill JR
J Hypertens; 1987 Oct; 5(5):593-8. PubMed ID: 2963065
[TBL] [Abstract][Full Text] [Related]
19. Influence of neurohumoral blockade on heart rate and blood pressure responses to haemorrhage in isoflurane anaesthetized rats.
Ullman J
Acta Physiol Scand; 2000 Jul; 169(3):189-94. PubMed ID: 10886033
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a vasodilatory effect of vasopressin in the conscious rat.
Walker BR
Am J Physiol; 1986 Jul; 251(1 Pt 2):H34-9. PubMed ID: 3755295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
